碧美斯(BMS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BMS 碧美斯

盘前交易 09-10 09:02:10 EDT

57.25

+0.00

0.00%

最高57.25	最低57.25	成交量0.00
今开57.25	昨收57.25	日振幅0.00%
总市值52.22亿	流通市值51.69亿	总股本9,121万
成交额0.00	换手率0.00%	流通股本9,029万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BMS","market":"US","secType":"STK","nameCN":"碧美斯","latestPrice":57.25,"timestamp":1708635600000,"preClose":57.25,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":90294980,"shares":91211990,"eps":2.5238,"marketStatus":"盘前交易","change":0,"latestTime":"09-10 09:02:10 EDT","open":57.25,"high":57.25,"low":57.25,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.5238,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":57.25,"volumeRatio":0},"requestUrl":"/m/hq/s/BMS","defaultTab":"news","newsList":[{"id":"2661325043","title":"百利天恒依据首例给药临床试验确认17亿元里程碑收入，BMS尚未打款缺少实质性临床终点数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2661325043","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661325043?lang=zh_cn&edition=full","pubTime":"2026-08-21 15:08","pubTimestamp":1787296080,"startTime":"0","endTime":"0","summary":"百利天恒，于2023年1月登陆上交所科创板。即使抛开上述的勾稽关系断裂不谈，该笔17.76亿元里程碑收入的确认时点同样令人费解，或涉嫌利用会计估计的自由裁量权提前确认收入以粉饰报表，或误导投资者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-21/doc-inipaenp6496930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MDTX","688506","IBBJ","91194","BMS","BMED","PSYK","BK0239","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658596249","title":"第三方BMS市占率第一！力高新能3.9亿元安徽合肥基地封顶","url":"https://stock-news.laohu8.com/highlight/detail?id=2658596249","media":"市场资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658596249?lang=zh_cn&edition=full","pubTime":"2026-08-11 14:09","pubTimestamp":1786428540,"startTime":"0","endTime":"0","summary":"力高新能当前正冲刺创业板IPO，于2026年3月27日获深交所受理，4月17日进入问询状态。另据招股书申报稿信息，力高新能在2024年及2025年中国新能源乘用车BMS市场中，装机量仅次于比亚迪及宁德时代位列第三，在第三方BMS厂商中排名第一。2025年，力高新能BMS出货320万套，占据市场约20%份额，业务覆盖汽车电子、储能、新能源汽车代工三大板块。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-11/doc-inimxmep7590560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655868154","title":"BMS加码投资AI制药 效率提升尚待临床验证","url":"https://stock-news.laohu8.com/highlight/detail?id=2655868154","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655868154?lang=zh_cn&edition=full","pubTime":"2026-07-29 16:50","pubTimestamp":1785315025,"startTime":"0","endTime":"0","summary":"美国制药巨头百时美施贵宝（Bristol-MyersSquibb，NYSE:BMY，简称“BMS”）日前宣布，将采购搭载英伟达（NVIDIA）VeraRubinNVL72系统的DGXSuperPOD超级计算机。BMS表示，这将是生命科学领域最强大、最高效、由单一企业拥有的英伟达基础设施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607293825137022.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607293825137022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["VTHR","ARTY","AIPO","BK1191","AGIX","CHAT","BMS","01477","BK1574","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653737746","title":"BMS的留白，诺诚健华的窗口","url":"https://stock-news.laohu8.com/highlight/detail?id=2653737746","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653737746?lang=zh_cn&edition=full","pubTime":"2026-07-22 15:36","pubTimestamp":1784705799,"startTime":"0","endTime":"0","summary":"更关键的产业意义在于：全球第一个用于特应性皮炎的TYK2抑制剂，大概率将出自诺诚健华之手。BMS的留白，诺诚健华的窗口全球TYK2先驱BMS的Deucravacitinib选择了另一条路：聚焦银屑病、银屑病关节炎、系统性红斑狼疮，未大规模开展针对特应性皮炎的关键注册临床。BMS这一战略留白，恰好让出了一道窄门。在特应性皮炎这条BMS放弃的赛道上，诺诚健华的坚持正在得到回报。全球权益的含金量一个值得注意的事实是，诺诚健华至今仍持有ICP-332的全部全球权益。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1784604125251670229","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1161","BK1574","BK0239","688428","09969","BMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651565412","title":"均普智能将携全球首条多台机器人并线作业BMS自主量产中试产线亮相2026 WAIC","url":"https://stock-news.laohu8.com/highlight/detail?id=2651565412","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651565412?lang=zh_cn&edition=full","pubTime":"2026-07-16 16:06","pubTimestamp":1784189192,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ROBO","KOMP","BMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029599","title":"招中标日报｜0.62元/Wh，国峰元储中标150MW/600MWh储能成套设备","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029599","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645029599?lang=zh_cn&edition=full","pubTime":"2026-06-22 18:23","pubTimestamp":1782123780,"startTime":"0","endTime":"0","summary":"中电建拟中标宝鸡市大项目6月22日，扶风段家100MW/200MWh电网侧储能电站项目EPC总承包中标结果公示。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-06-22/doc-iniehsct9303579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4183","EPC","PCS","BMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642264255","title":"40亿美元买来的AI药物，III期头对头打败BMS，预计明年上市！","url":"https://stock-news.laohu8.com/highlight/detail?id=2642264255","media":"智药局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642264255?lang=zh_cn&edition=full","pubTime":"2026-06-12 18:03","pubTimestamp":1781258580,"startTime":"0","endTime":"0","summary":"一款AI药物，III期实验成功！昨晚，武田公布了这款TYK2药物的最新III期临床信息。数据显示，该药物头对头疗效直接完胜BMS同靶点药物Sotyktu！武田计划在2027年上半年，将zasocitinib正式推向市场。由此，Sotyktu成为全球首款获批上市的TYK2抑制剂。目前该药物已经以1亿元首付款成功对外授权。这是中国率先由AI辅助设计、进入III期确证性临床的小分子药物。III期试验计划在中国招募约750名超重或肥胖受试者，进行52周评估，预计2028年底或2029年上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-06-12/doc-iniccwvp3522336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CHAT","AGIX","BMS","III","IPOS","BK4134","ARTY","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639725276","title":"BMS多发性骨髓瘤III期数据亮眼 C4 Therapeutics受提振大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2639725276","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639725276?lang=zh_cn&edition=full","pubTime":"2026-05-30 03:49","pubTimestamp":1780084140,"startTime":"0","endTime":"0","summary":"百时美施贵宝日前公布了其在研药物美齐格米德的III期临床试验阳性数据。结果显示，该联合疗法将复发或难治性多发性骨髓瘤患者的疾病进展或死亡风险降低了52%。这一积极结果不仅推高了施贵宝的股价，也显著提振了同领域生物科技公司C4 Therapeutics的市场表现。　　在施贵宝宣布这一消息后，C4 Therapeutics股价应声大涨，盘中一度触及52周新高，最终收涨逾19%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-30/doc-inhzrera0552232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4134","III","BMS","LENZ","BK4007","BK4539","CCCC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639643171","title":"信达再获百亿美元大单，Co-Co模式从“练兵”走向常态化","url":"https://stock-news.laohu8.com/highlight/detail?id=2639643171","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639643171?lang=zh_cn&edition=full","pubTime":"2026-05-29 10:32","pubTimestamp":1780021920,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛一年之内，两次以Co-Co（共同开发与共同商业化）模式站上全球BD交易舞台的中心，信达生物正在为中国创新药出海写下新注脚。5月29日，信达生物在港交所公告，与辉瑞就12个具有突破性潜力的肿瘤早期及源头创新研发项目签署全球战略许可及合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605293754033177.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605293754033177.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0321505439.SGD","SGXZ57979304.SGD","LU1066053197.SGD","LU0058720904.USD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4599","LU2242644610.SGD","LU1969619763.USD","LU0456855351.SGD","IE00BLSP4452.SGD","LU1894683264.USD","BK1161","LU0225771236.USD","LU1023059063.AUD","LU2097828474.EUR","LU0234572021.USD","BK4534","LU0122379950.USD","IE000M9KFDE8.USD","HK0000165453.HKD","LU0225284248.USD","LU0170899867.USD","SG9999002232.USD","SG9999002224.SGD","PFE","LU2328871848.SGD","BK1583","LU0289739699.SGD","BK4585","BK4588","LU2097828805.USD","SG9999011175.SGD","BK4007","IE00BLSP4239.USD","LU0306807586.USD","SG9999003800.SGD","BK4581","LU1057294990.SGD","BK1589","LU0502904849.HKD","IE00B19Z3581.USD","01801","BK4568","BK4592","BMS","BK4550","LU2488822045.USD","SG9999001176.USD","IE00B3T34201.USD","LU1894683348.USD","LU0985481810.HKD","LU1883839398.USD","SG9999001176.SGD","LU2097828714.EUR","LU2097828631.EUR","SG9999013999.USD","LU0321505868.SGD","LU0455707207.USD","BK4533","IE00BBT3K403.USD","LU0306806265.USD","LU0868494617.USD","LU1066051498.USD","LU2097828557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639141306","title":"A股申购 | 高特电子(301669.SZ)开启申购 产品涵盖应用于数据中心等领域的后备电源BMS","url":"https://stock-news.laohu8.com/highlight/detail?id=2639141306","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639141306?lang=zh_cn&edition=full","pubTime":"2026-05-29 06:44","pubTimestamp":1780008250,"startTime":"0","endTime":"0","summary":"报告期内，公司储能BMS相关产品广泛应用于电源侧/电网侧大型高压储能电站，以及工商业储能、户用储能等领域，同时公司产品也涵盖应用于数据中心、通信基站、轨道交通等领域的后备电源BMS，应用于新能源汽车、电动船舶等领域的动力电池BMS，以及电力检测等相关业务。公司在大型储能BMS领域产品出货量持续保持市场领先地位，具有较高的市场知名度和品牌认可度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399300","BLOK","159982","BMS","DTCR","301669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635035758","title":"Atrium Therapeutics Q1净亏损1660万美元，BMS里程碑付款支撑收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2635035758","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635035758?lang=zh_cn&edition=full","pubTime":"2026-05-15 23:41","pubTimestamp":1778859660,"startTime":"0","endTime":"0","summary":"　　Atrium Therapeutics公布2026年第一季度财报。公司报告期内净亏损为1663万美元，合每股亏损0.97美元。作为对比，公司在作为Avidity Biosciences子公司期间的2025年同期净亏损为745万美元，合每股亏损0.44美元。需要说明的是，由于Atrium于2026年2月27日才完成从Avidity的分拆独立上市，本期财务数据不宜直接与历史同期进行比较。　　Atrium于2月27日正式作为独立公司登陆纳斯达克。ATR 1072的IND申请预计于2026年下半年提交，ATR 1086的IND申请预计于2027年提交。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-15/doc-inhxyyie6355365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","RNA","BK4585","LENZ","BK4539","BK4007","BK4505","IE0009354923.USD","BK4588","BMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635027823","title":"大摩：恒瑞医药(01276)与BMS缔152亿美元战略合作 加速全球化进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2635027823","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635027823?lang=zh_cn&edition=full","pubTime":"2026-05-13 10:43","pubTimestamp":1778640196,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利发布研报称，恒瑞医药(01276)与百时美施贵宝宣布一项涵盖13个临床前资产的全球战略合作，总交易价值达152亿美元(下同)。当中包括6亿美元预付款、2027至2028年合共3.5亿美元周年付款、最高143亿美元里程碑付款，以及分级销售里程权利金。该行维持恒瑞为中国医疗保健行业首选股，予“增持”评级，H股目标价92港元。该行认为，这项涵盖多种形式及资产模态的战略合作，进一步验证恒瑞医药的早期研发平台及提升的全球化能力。除了短期现金收益外，双向合作结构及共同开发与商业化选项，亦有望加快恒瑞的全球化步伐，并为其在中国市场不断扩展的免疫学产品组合带来商业协同效应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441038.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","LU2148510915.USD","LU1255011170.USD","LU1064130708.USD","LU2097828474.EUR","LU0359202008.SGD","LU1064131003.USD","LU1997244956.HKD","LU2495084118.USD","LU2580892862.HKD","BK0239","LU2097828805.USD","LU1023057109.AUD","LU1781817850.SGD","LU0405327494.USD","BK0012","LU2289578879.USD","LU2328871848.SGD","LU2097828631.EUR","LU1820825898.SGD","BK0028","BK0183","LU2543165471.USD","LU1146622755.USD","LU2488822045.USD","LU0359201612.USD","LU1655091616.SGD","LU1997245094.SGD","LU1328615791.USD","LU1580142542.USD","LU2580892789.USD","LU2097828557.USD","BK0188","LU2097828714.EUR","BK0060","600276","BK0196","LU1997245177.USD","01276","LU0405327148.USD","LU0359201885.HKD","LU1969619763.USD","BMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634248737","title":"与跨国药企BMS双向授权，恒瑞医药拿下152亿美元BD大单，股价为何冲高回落？","url":"https://stock-news.laohu8.com/highlight/detail?id=2634248737","media":"时代财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634248737?lang=zh_cn&edition=full","pubTime":"2026-05-12 22:26","pubTimestamp":1778595960,"startTime":"0","endTime":"0","summary":"5月12日，A股医药板块迎来重磅消息。医药“老大哥”恒瑞医药（600276.SH；01276.HK）午后股价直线拉升，A股盘中一度触及涨停，港股一度涨超16%。不过，市场的亢奋情绪并未持续至收盘。随后股价震荡回落，截至收盘，恒瑞医药A股、港股涨幅均收窄至4.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605123734861793.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605123734861793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0196","LU2148510915.USD","01276","BK0188","600276","LU1655091616.SGD","LU2289578879.USD","LU2488822045.USD","LU1820825898.SGD","BK0028","LU0405327494.USD","LU1997245177.USD","LU2097828474.EUR","LU1023057109.AUD","LU1064130708.USD","BK0239","LU1781817850.SGD","LU2097828557.USD","LU2328871848.SGD","LU1146622755.USD","LU2097828631.EUR","LU0359201612.USD","LU1997245094.SGD","LU2495084118.USD","LU1969619763.USD","LU1064131003.USD","LU2543165471.USD","BK1191","BMS","LU1328615791.USD","LU2097828805.USD","BK0060","LU1580142542.USD","LU0359201885.HKD","LU2580892862.HKD","LU0405327148.USD","LU1255011170.USD","LU1997244956.HKD","LU0359202008.SGD","LU2097828714.EUR","LU2580892789.USD","BK0183","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634291117","title":"跨国巨头再现百亿美元级“天价”收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2634291117","media":"第一财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634291117?lang=zh_cn&edition=full","pubTime":"2026-05-12 16:59","pubTimestamp":1778576361,"startTime":"0","endTime":"0","summary":"5月12日，恒瑞医药宣布，百时美施贵宝（BMS）与恒瑞医药达成授权协议，BMS将向恒瑞医药支付最高达9.5亿美元的相关付款，该协议的潜在总交易额可达约152亿美元。受该消息提振，恒瑞医药港股（1276.HK）股价一度上涨约15%。这项协议涵盖了恒瑞医药的13项创新项目，包括肿瘤学、血液学及免疫学。不过声明称，这些项目仍然处于早期研发阶段，尚未进入临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605123734535143.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605123734535143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1655091616.SGD","LU1023057109.AUD","BK0012","LU1146622755.USD","BK0188","LU2097828714.EUR","LU1064131003.USD","LU1820825898.SGD","LU0405327494.USD","LU2580892862.HKD","LU1969619763.USD","LU0359201885.HKD","01276","LU2543165471.USD","BK0183","LU2328871848.SGD","600276","LU2097828631.EUR","LU1781817850.SGD","LU2097828474.EUR","LU1064130708.USD","LU2289578879.USD","LU1328615791.USD","LU1580142542.USD","LU2488822045.USD","BK1191","LU0359202008.SGD","LU1997245177.USD","BK0239","LU2495084118.USD","LU0405327148.USD","LU1255011170.USD","BK0060","LU2148510915.USD","LU0359201612.USD","LU1997244956.HKD","LU1997245094.SGD","BK0028","BK0196","LU2097828557.USD","LU2097828805.USD","LU2580892789.USD","BMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634672260","title":"152亿美元！恒瑞与BMS刷新合作纪录，股价同步拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=2634672260","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634672260?lang=zh_cn&edition=full","pubTime":"2026-05-12 14:43","pubTimestamp":1778568180,"startTime":"0","endTime":"0","summary":"5月12日午间休盘时段，恒瑞医药（600276.SH；01276.HK）公告与百时美施贵宝公司（下称“BMS”）达成全球战略合作及许可协议，共同推进13款涵盖肿瘤学、血液学及免疫学的早期项目，以加速创新药物研发。根据协议条款，BMS将向恒瑞医药支付可达9.5亿美元的相关付款，即6亿美元首付款、第一笔周年付款1.75亿美元，以及第二笔有条件的2028年周年付款1.75亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605123734393223.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605123734393223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634326269","title":"恒瑞医药港股午后拉升涨逾15% 与BMS达成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2634326269","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634326269?lang=zh_cn&edition=full","pubTime":"2026-05-12 13:11","pubTimestamp":1778562660,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　恒瑞医药港股午后跳升15%，最高触及76.75港元。\n\n　　消息面上，恒瑞医药（01276.HK）公布，公司与百时美施贵宝公司（简称“BMS”）达成全球战略合作及许可协议，共同推进13款涵盖肿瘤学、血液学及免疫学的早期项目，以加速创新药物研发，惠及全球患者。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郝欣煜","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-05-12/doc-inhxrfsi1348547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2097828631.EUR","600276","LU0359201612.USD","LU1997245094.SGD","LU2097828474.EUR","BK0028","LU1064130708.USD","LU2495084118.USD","LU2097828557.USD","LU2097828714.EUR","BK1191","BK0183","LU1023057109.AUD","LU1064131003.USD","LU2543165471.USD","BMS","LU1969619763.USD","LU2328871848.SGD","LU2289578879.USD","LU2488822045.USD","LU1781817850.SGD","BK4588","LU1580142542.USD","LU2097828805.USD","LU0359201885.HKD","BK0239","01276","BK0060","LU1655091616.SGD","LU1146622755.USD","LU0405327494.USD","BK4585","LU2148510915.USD","BK0196","LU1997244956.HKD","LU1255011170.USD","LU0405327148.USD","BK0012","LU1997245177.USD","LU2580892862.HKD","VXUS","LU2580892789.USD","LU1328615791.USD","LU0359202008.SGD","LU1820825898.SGD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632621072","title":"奋斗的青春最美丽！青岛这位青年汽修工全力护航美好出行路","url":"https://stock-news.laohu8.com/highlight/detail?id=2632621072","media":"观海新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632621072?lang=zh_cn&edition=full","pubTime":"2026-05-02 11:00","pubTimestamp":1777690800,"startTime":"0","endTime":"0","summary":"青岛日报社/观海新闻5月2日讯 “五一”假期，青岛城运汽车服务集团崂山汽车服务有限公司的青年汽修工王鸿斌依然坚守在岗位上，为市民游客的美好出行保驾护航。面对不解和疑问，王鸿斌坦言，选择国有汽修企业，看中的是企业多年传承的深厚技术底蕴和良好的赋能机制，这会给青年职工提供良好的发展前景。这是王鸿斌的师傅、汽修高级技师董正锋对他的评价。在查阅相关资料和类似维修案例后，王鸿斌判断故障可能出现在线束上。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-05-02/doc-inhwnnkk9859366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627410921","title":"以“新”提“质”加足安徽新能源汽车产业发展马力","url":"https://stock-news.laohu8.com/highlight/detail?id=2627410921","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2627410921?lang=zh_cn&edition=full","pubTime":"2026-04-14 18:36","pubTimestamp":1776162992,"startTime":"0","endTime":"0","summary":"中新网合肥4月14日电订单饱满、产线高速运转、新品密集落地……近日，“牢记嘱托开新局日新江淮往前赶”采访团走进位于安徽省合肥市的多家新能源汽车配件企业。记者在现场看到一个个新技术、新工艺、新产品被应用于新能源汽车领域，为汽车产业集群发展助发展之力。安徽作为新能源汽车产业的重要集聚地，已集聚7家整车企业，引育数千家规上零部件企业与后市场企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604143704548589.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604143704548589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626161644","title":"今日招中标动态｜0.5100-0.5196元/Wh！甘肃玉门油田80MW/320MWh风电配套储能系统中标公示","url":"https://stock-news.laohu8.com/highlight/detail?id=2626161644","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2626161644?lang=zh_cn&edition=full","pubTime":"2026-04-10 13:48","pubTimestamp":1775800080,"startTime":"0","endTime":"0","summary":"中标项目1、0.5100-0.5196元/Wh！甘肃玉门油田80MW/320MWh风电配套储能系统中标公示4月9日，中国石油玉门油田红柳泉新能源基地一期50万千瓦风电项目储能系统候选人公示。中国石油集团济柴动力/智光储能/远景能源三家入围公示，投标单价范围0.5100-0.5196元/Wh。甘肃白银30MW风电配储中标候选人公示4月8日，大唐电子商务平台发布甘肃公司景泰风电公司大唐景泰30MW分散式风电项目磷酸铁锂电池储能系统中标候选人公示。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-10/doc-inhtywee0303569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620041322","title":"新疆3.2GWh昌吉国投储能系统设备采购终止！","url":"https://stock-news.laohu8.com/highlight/detail?id=2620041322","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2620041322?lang=zh_cn&edition=full","pubTime":"2026-03-20 12:26","pubTimestamp":1773980760,"startTime":"0","endTime":"0","summary":"2月10日，昌吉国投鑫能源开发有限公司发布4个共享储能项目储能系统设备采购招标，总规模达800MW/3200MWh。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-03-20/doc-inhrreqy4078415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PCS","BMS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bemis.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0138},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1512},{"period":"1year","weight":0.1723},{"period":"ytd","weight":0.118}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"<p>碧美斯有限公司成立于 1885年5月18日,是一家生产软包装产品和压力敏感材料的公司,销售的客户遍及北美、拉丁美洲、欧洲和亚太地区。公司的业务活动都是围绕它的两个业务部门:灵活包装和压力敏感材料。截至2011年12月31日 ,大约89%的公司的销售额来自软包装段，大约11%来自压力敏感材料段。</p>","exchange":"NYSE","name":"碧美斯","nameEN":"Bemis"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"碧美斯(BMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供碧美斯(BMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"碧美斯,BMS,碧美斯股票,碧美斯股票老虎,碧美斯股票老虎国际,碧美斯行情,碧美斯股票行情,碧美斯股价,碧美斯股市,碧美斯股票价格,碧美斯股票交易,碧美斯股票购买,碧美斯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"碧美斯(BMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供碧美斯(BMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}